Is anti-PD-1/PD-L1 immunotherapy sensitizing for conventional cancer therapies?

被引：0
|
作者：
Matias, M. [1 ]
Aspeslagh, S. [2 ]
Palomar, V. [3 ]
Lanoy, E. [4 ]
Dercle, L. [5 ]
Even, C. [3 ]
Ferte, C. [3 ]
Hollebecque, A. [2 ]
Marabelle, A. [2 ]
Massard, C. [2 ]
Soria, J-C. [2 ]
Postel-Vinay, S. [2 ]
机构：
[1] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[2] Inst Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[3] Inst Gustave Roussy, Dept Head & Neck Canc, Villejuif, France
[4] Inst Gustave Roussy, Dept Biostat, Villejuif, France
[5] Inst Cancerol Gustave Roussy, Nucl Med, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
10.1093/annonc/mdw378.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1073P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy
    Zhulai, Galina
    Oleinik, Eugenia
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
  • [2] Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer
    Ri, Myong Hak
    Ma, Juan
    Jin, Xuejun
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 281
  • [3] Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer
    Wang, Luyao
    Ma, Qingxia
    Yao, Ruixue
    Liu, Jia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 79
  • [4] In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?
    Aspeslagh, Sandrine
    Matias, Margarida
    Palomar, Virginia
    Dercle, Laurent
    Lanoy, Emilie
    Soria, Jean-Charles
    Postel-Vinay, Sophie
    EUROPEAN JOURNAL OF CANCER, 2017, 87 : 65 - 74
  • [5] Research trends on anti-PD-1/PD-L1 immunotherapy for esophageal cancer: A bibliometric analysis
    Yang, Yuanyuan
    Wang, Feng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Different Biomarker Modalities and Response to Anti-PD-1/PD-L1 Therapies
    Liu, Shufang
    Niu, Wenquan
    JAMA ONCOLOGY, 2020, 6 (02) : 298 - 299
  • [7] The anticancer immune response of anti-PD-1/PD-L1 and the genetic determinants of response to anti-PD-1/PD-L1 antibodies in cancer patients
    Sui, Xinbing
    Ma, Junhong
    Han, Weidong
    Wang, Xian
    Fang, Yong
    Li, Da
    Pan, Hongming
    Zhang, Li
    ONCOTARGET, 2015, 6 (23) : 19393 - 19404
  • [8] The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer
    Patrinely, James Randall, Jr.
    Dewan, Anna K.
    Johnson, Douglas B.
    BIODRUGS, 2020, 34 (04) : 495 - 503
  • [9] The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer
    James Randall Patrinely
    Anna K. Dewan
    Douglas B. Johnson
    BioDrugs, 2020, 34 : 495 - 503
  • [10] Exploring the feasibility of anti-PD-1/PD-L1 immunotherapy in endometriosis-associated ovarian cancer
    Gonzalez-Canto, Eva
    Mari-Alexandre, Josep
    Gilabert-Estelles, Juan
    FERTILITY AND STERILITY, 2022, 117 (01) : 169 - 170
12345